Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Screening for dementia: single yes/no question or Likert scale?

Baba M Aji and Andrew J Larner
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.17-1-93
Clin Med February 2017
Baba M Aji
Walton Centre for Neurology and Neurosurgery, Liverpool, UK
Roles: consultant neurologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J Larner
Roles: consultant neurologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Dementia is now a major public health issue, but the optimal method of screening for at-risk individuals is unclear. Government directive, from the Dementia Commissioning for Quality and Innovation (Dementia CQUIN),1 advocates a single screening question:Have you been more forgetful in the past 12 months to the extent that it has significantly affected your life?’

In an epilepsy clinic, a population of patients with a high frequency of subjective memory complaints, 48% of patients answered this simple memory screening question in the affirmative, suggesting it would have very low specificity and high probability of identifying false positives.2

Since subjective memory complaints (SMCs) may be associated with subsequent cognitive decline, dementia screening might reasonably be focused on this at-risk population. Screening tests for SMCs are available, such as the five-point Likert scale described by Paradise et al3 in which participants are asked ‘In general, how would you rate your memory?’ with a choice of the following five responses: 1 – poor; 2 – fair; 3 – good; 4 – very good; or, 5 – excellent. The scale defines those rating their memory fair or poor (2 or 1) as experiencing SMCs (SMC+).3 This Likert scale has been used as a screen for SMCs in diagnostic test accuracy studies of cognitive screening instruments for mild cognitive impairment (MCI), which in some instances is a prodromal stage of dementia.4

We administered the SMC Likert scale to 100 consecutive follow-up patients attending a dedicated epilepsy outpatient clinic. Patients were also asked for any examples of their memory problems. Based on Likert scores, groups were categorised as SMC+ (n=20) or SMC– (n=80) and compared (t tests for continuous variables, chi-squared tests for categorical variables; Table 1).

View this table:
  • View inline
  • View popup
Table 1.

Demographic and diagnostic details of consecutive follow-up epilepsy patients (n=100) administered the SMC Likert rating scale

No difference was found in patient age or seizure type (generalised or partial) between SMC+ and SMC– groups. However, there were significant differences in duration of epilepsy and use of antiepileptic drugs (monotherapy versus polytherapy), with longer disease duration and increased frequency of polytherapy in the SMC+ group.

All SMC+ patients commented on memory issues. No SMC– patient with Likert scale scores of 4 or 5 had any memory-related comment, although all SMC– patients with score of 3 did recount examples of memory problems.

This study found a much lower self-rating of memory impairment using the Likert scale than a previous epilepsy clinic-based study that used a single yes/no screening question (20% versus 48%). The single question study found no statistically significant difference in patient age, seizure type, use of anti-epileptic drugs, or duration of epilepsy (trend) between those answering yes or no to the screening question,2 whereas the Likert scale did identify significant differences between epilepsy duration and use of polytherapy between SMC+ and SMC– groups, factors likely to be associated with increasing memory impairment.

Using a Likert scale screening question may provide greater diagnostic discrimination than a simple yes/no question, concordant with evidence that longer cognitive screening instruments have greater diagnostic accuracy.5 Therefore, we suggest that policy on dementia screening might explore this approach.

Conflicts of interest

The authors have no conflicts of interest to declare.

  • © Royal College of Physicians 2017. All rights reserved.

References

  1. ↵
    1. Department of Health
    . Using the Commissioning for Quality and Innovation (CQUIN) payment framework. Guidance on the new national goals 2012–13. London: Department of Health, 2012.
  2. ↵
    1. Aji BM
    , Larner AJ. Screening for dementia: is one simple question the answer? Clin Med 2015;15:111–2.
    OpenUrlFREE Full Text
  3. ↵
    1. Paradise MB
    , Glozier NS, Naismith SL, Davenport TA, Hickie IB. Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: a cross-sectional study. BMC Psychiatry 2011;11:108.
    OpenUrlCrossRefPubMed
  4. ↵
    1. O’Caoimh R
    , Timmons S, Molloy DW. Screening for mild cognitive impairment: comparison of “MCI specific” screening instruments. J Alzheimers Dis 2016;51:619–29.
    OpenUrl
  5. ↵
    1. Larner AJ.
    Performance-based cognitive screening instruments: an extended analysis of the time versus accuracy trade-off. Diagnostics 2015;5:504–12.
    OpenUrl
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Screening for dementia: single yes/no question or Likert scale?
Baba M Aji, Andrew J Larner
Clinical Medicine Feb 2017, 17 (1) 93-94; DOI: 10.7861/clinmedicine.17-1-93

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Screening for dementia: single yes/no question or Likert scale?
Baba M Aji, Andrew J Larner
Clinical Medicine Feb 2017, 17 (1) 93-94; DOI: 10.7861/clinmedicine.17-1-93
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Conflicts of interest
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • DIAGNOSTIC ACCURACY OF A NOCTURIA SINGLE QUESTION SCALE AS A PREDICTOR OF SEVERITY OF LOWER URINARY TRACT SYMPTOMS IN MEN
  • Google Scholar

More in this TOC Section

  • Does ultrasound-guided peripheral cannulation training for junior doctors reduce missed intravenous antibiotics doses? A teaching programme for foundation doctors in an acute medical unit
  • Unexpected deaths following discharge of medical patients from hospital
  • Promoting electric vehicle uptake, a job for the NHS?
Show more Clinical and scientific letters

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians